Does LOMUSTINE Cause Malignant neoplasm progression? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Malignant neoplasm progression have been filed in association with LOMUSTINE (LOMUSTINE). This represents 3.8% of all adverse event reports for LOMUSTINE.
62
Reports of Malignant neoplasm progression with LOMUSTINE
3.8%
of all LOMUSTINE reports
16
Deaths
12
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LOMUSTINE?
Of the 62 reports, 16 (25.8%) resulted in death, 12 (19.4%) required hospitalization, and 2 (3.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMUSTINE. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does LOMUSTINE Cause?
Death (169)
Off label use (135)
Thrombocytopenia (127)
Disease progression (106)
Neutropenia (92)
Drug ineffective (88)
Fatigue (71)
Nausea (68)
Platelet count decreased (63)
Product use in unapproved indication (58)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LOMUSTINE Alternatives Have Lower Malignant neoplasm progression Risk?
LOMUSTINE vs LONAPEGSOMATROPIN-TCGD
LOMUSTINE vs LONCASTUXIMAB TESIRINE-LPYL
LOMUSTINE vs LOPERAMIDE
LOMUSTINE vs LOPINAVIR
LOMUSTINE vs LOPINAVIR\RITONAVIR